Faculty of Medicine, South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia
Gastroenterology Research Group, The Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.
BMJ Open. 2020 Nov 4;10(11):e039503. doi: 10.1136/bmjopen-2020-039503.
Evidence regarding effective communication between clinicians and patients with inflammatory bowel disease (IBD) is limited. Studies that investigate clinical communication in IBD are much fewer in number than studies that investigate the perceptions of patients and clinicians about communication in clinical encounters. The current review aims to identify, organise and summarise systematically what is currently known about (1) the characteristics of interactions between clinicians who manage IBD and patients with IBD, and (2) how clinical discussion affects health outcomes in IBD.
Scopus, PubMed, Embase, Communication Abstracts, Health & Society, Linguistics and Language Behavior Abstracts and PsycINFO will be systematically searched for studies that investigate the characteristics of IBD clinical interactions during recorded consultations, from earliest available dates within each database to May 2020. A specifically developed quality assessment tool, grounded in linguistic theory, will be used to critically assess the evidence. In addition, a data extraction template will be developed and utilised to provide a description of the characteristics of IBD clinical communication as well as an estimation of its effect on health outcomes in a narrative synthesis.
Ethical review and approval is not required for this systematic review as no primary data will be collected. The results will be published in peer-reviewed journals and presented at academic conferences.
International Prospective Register of Systematic Reviews (PROSPERO) on 28 April 2020 (registration number: CRD42020169657).
有关临床医生与炎症性肠病（IBD）患者之间有效沟通的证据有限。研究 IBD 临床沟通的数量远少于研究患者和临床医生对临床交流中沟通的看法。本综述旨在系统地确定、组织和总结以下方面的知识：（1）管理 IBD 的临床医生与 IBD 患者之间互动的特征；（2）临床讨论如何影响 IBD 的健康结果。
将从每个数据库最早可用日期至 2020 年 5 月，系统地在 Scopus、PubMed、Embase、Communication Abstracts、Health & Society、Linguistics and Language Behavior Abstracts 和 PsycINFO 中搜索调查记录咨询期间 IBD 临床互动特征的研究。将使用基于语言学理论的专门开发的质量评估工具对证据进行严格评估。此外，将开发并利用数据提取模板，以叙述性综合的方式描述 IBD 临床沟通的特征，并估计其对健康结果的影响。
由于不收集原始数据，因此本系统评价不需要伦理审查和批准。研究结果将发表在同行评议的期刊上，并在学术会议上展示。
国际前瞻性注册系统评价（PROSPERO）注册日期：2020 年 4 月 28 日（注册编号：CRD42020169657）。
